Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.

被引:48
作者
Leong T.T. [1 ]
Fearon U. [1 ]
Veale D.J. [1 ]
机构
[1] Department of Rheumatology, St. Vincent's University Hospital and The Conway Institute of Biomolecular and Biomedical Research, University College Dublin
关键词
Vascular Endothelial Growth Factor; Psoriasis; Infliximab; Pioglitazone; Psoriatic Arthritis;
D O I
10.1007/s11926-005-0044-5
中图分类号
学科分类号
摘要
Psoriasis is a common chronic dermatosis occurring in 2% of the population and associated with an inflammatory arthritis--psoriatic arthritis (PsA)--in up to 40% of cases. PsA accounts for approximately 15% of patients attending early synovitis clinics, therefore it represents the second most common diagnostic category after rheumatoid arthritis. There are a number of common pathogenic features that link the skin and the joint inflammatory processes. Angiogenesis appears to be a fundamental inflammatory response early in the pathogenesis and significant abnormalities of vascular morphology and angiogenic growth factors have been described in psoriasis and PsA. This paper will explore the recent published evidence to support the hypothesis that dysregulated angiogenesis provides a primary pathogenic mechanism in psoriasis skin and in the PsA joint.
引用
收藏
页码:325 / 329
页数:4
相关论文
共 50 条
  • [41] Outcome Measures in Psoriasis and Psoriatic Arthritis
    Kim N.
    Gottlieb A.B.
    Current Dermatology Reports, 2013, 2 (3) : 159 - 163
  • [42] JAK Inhibitors for Psoriasis and Psoriatic Arthritis
    Aakaash Varma
    George Han
    Current Dermatology Reports, 2020, 9 : 107 - 113
  • [43] New therapies for psoriasis and psoriatic arthritis
    Ritchlin, Christopher T.
    Krueger, James G.
    CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (03) : 204 - 210
  • [44] Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
    Yi, Robin C.
    Akbik, Maya
    Smith, Logan R.
    Klionsky, Yael
    Feldman, Steven R.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [45] Psoriatic arthritis and psoriasis: differential diagnosis
    Maddalena Napolitano
    Francesco Caso
    Raffaele Scarpa
    Matteo Megna
    Angela Patrì
    Nicola Balato
    Luisa Costa
    Clinical Rheumatology, 2016, 35 : 1893 - 1901
  • [46] Certolizumab Pegol for Psoriasis and Psoriatic Arthritis
    Vidhatha Reddy
    Quinn Thibodeaux
    John Koo
    Current Dermatology Reports, 2020, 9 : 100 - 106
  • [47] Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
    Savage L.J.
    Wittmann M.
    McGonagle D.
    Helliwell P.S.
    Rheumatology and Therapy, 2015, 2 (1) : 1 - 16
  • [48] Osteoporosis in Psoriasis and Psoriatic Arthritis Patients
    Mohammed, Jinan Q.
    Mathkhor, Abdulsatar J.
    Abed, Alaa H.
    WORLD FAMILY MEDICINE, 2020, 18 (07): : 38 - 42
  • [49] The Microbiome in Psoriasis and Psoriatic Arthritis: Joints
    Scher, Jose U.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (06) : 32 - 35
  • [50] TNF Inhibitors for Psoriasis and Psoriatic Arthritis
    Cardwell L.A.
    Sullivan B.
    Baran E.
    Oussedik E.
    Feldman S.R.
    Current Dermatology Reports, 2017, 6 (2) : 113 - 120